2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
Insurance Revenue | -- | -- | -- | -- | -- | -- |
Interest Income | -- | -- | -- | -- | -- | -- |
Turnover | -- | -- | -- | -- | -- | -- |
Gross Premium Income | 27,535,275 | 24.092% | 22,189,381 | 20,480,119 | 16,708,504 | 14,629,589 |
Net Premium Income | 27,426,131 | 24.156% | 22,090,061 | 18,885,094 | 16,215,204 | 12,801,451 |
Investment Income/(Loss) | 408,709 | -76.783% | 1,760,361 | 953,035 | 854,463 | 1,062,902 |
Net Realised Gains/(Losses) on Assets | -- | -- | -- | 1,114,885 | 673,035 | 712,884 |
Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | 126,760 | (25,517) | 169,896 |
Other Income/(Loss) | 5,695,937 | 404.414% | 1,129,219 | 860,586 | 775,978 | 376,831 |
Total Revenues | 33,530,777 | 34.232% | 24,979,641 | 21,940,360 | 18,493,163 | 15,123,964 |
Insurance Service Expenses | -- | -- | -- | -- | -- | -- |
Net Expenses from Reinsurance Contracts | -- | -- | -- | -- | -- | -- |
Net Finance (Expenses)/Income from Insurance Contracts | -- | -- | -- | -- | -- | -- |
Net Finance (Expenses)/Income from Reinsurance Contracts | -- | -- | -- | -- | -- | -- |
Net Impairment Loss | -- | -- | -- | -- | -- | -- |
Other Expenses | (29,427,577) | 10.438% | (26,646,319) | (21,073,608) | (18,312,921) | (15,690,856) |
Other Non-operating Items | -- | -- | 0 | 0 | 0 | 0 |
Share of results of Associates & JCEs | (93,239) | 477.510% | (16,145) | (37,635) | (33,712) | (43,946) |
Profit / (Loss) before Taxation | 4,009,961 | -- | (1,682,823) | 829,117 | 146,530 | (610,838) |
Taxation | (164,683) | -- | 298,406 | (72,018) | 107,850 | (27,807) |
Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | 232,577 | -14.495% | 272,003 | 407,491 | 299,406 | 184,544 |
Others | -- | -- | -- | -- | -- | -- |
Profit/ (Loss) Attributable to Shareholders | 4,077,855 | -- | (1,112,414) | 1,164,590 | 553,786 | (454,101) |
2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
Depreciation & Amortisation | 275,969 | -2.423% | 282,823 | 306,605 | 315,012 | 296,027 |
Directors' Emoluments | 9,742 | -6.820% | 10,455 | 3,072 | 2,903 | 3,839 |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
EPS (cts) | 277.000 | -- | -76.000 | 79.000 | 38.000 | -31.000 |
DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
Cash flow per share ($) | 1.502 | -- | (0.478) | (0.410) | 3.306 | (0.827) |
NBV per share ($) | 13.657 | -- | 10.727 | 11.395 | 10.685 | 10.145 |
Remarks: | Real time quote last updated: 23/08/2024 18:00 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,077,855 |
%Change | -- |
EPS / (LPS) | RMB 2.770 |
NBV Per Share (¥) | RMB 13.657 |